SLC1A3 and breast carcinoma: For example, a resent study reported that silencing FN1 inhibits YAP1/Hippo pathway activation by enhancing YAP1 phosphorylation, reduces aspartate uptake and utilization via SLC1A3, and suppresses breast cancer cell proliferation, invasion, migration and promotes apoptosis [17].